Ze Mi
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Cancer Research and Treatments 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Pengfei Rong (21 shared papers)Zhichao Feng (4 shared papers)Wenhu Zhou (6 shared papers)Mengtian Ma (3 shared papers)Jiahao Liu (7 shared papers)Xiao Hui Yang (2 shared papers)Hongpei Tan (11 shared papers)Dingbin Liu (2 shared papers)
In The Last Decade
Ze Mi
27 papers receiving 848 citations
Peers
Comparison fields: 5 of 89
- Biotechnology 130
- Drug Discovery 3
- Infectious Diseases 180
- Biomaterials 63
- Electronic, Optical and Magnetic Materials 46
Countries citing papers authored by Ze Mi
This map shows the geographic impact of Ze Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Mi more than expected).
Fields of papers citing papers by Ze Mi
This network shows the impact of papers produced by Ze Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Mi. The network helps show where Ze Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ze Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 237 | |
| 2 | 2020 | 75 | |
| 3 | 2020 | 74 | |
| 4 | 2022 | 68 | |
| 5 | 2019 | 64 | |
| 6 | 2019 | 57 | |
| 7 | 2014 | 37 | |
| 8 | 2015 | 37 | |
| 9 | 2022 | 30 | |
| 10 | 2024 | 26 | |
| 11 | 2025 | 22 | |
| 12 | 2022 | 16 | |
| 13 | 2023 | 16 | |
| 14 | 2024 | 16 | |
| 15 | 2024 | 15 | |
| 16 | 2014 | 11 | |
| 17 | 2025 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2022 | 6 |
About Ze Mi
Ze Mi is a scholar working on Biotechnology, Hepatology, Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 27 papers that have together received 855 indexed citations. Recurring topics across this work include Cancer Research and Treatments (5 papers), Nanoplatforms for cancer theranostics (4 papers), Alzheimer's disease research and treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Radiation Therapy and Dosimetry (3 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Biotechnology (130 citations), Drug Discovery (3 citations), Infectious Diseases (180 citations), Biomaterials (63 citations) and Electronic, Optical and Magnetic Materials (46 citations). Ze Mi has collaborated with scholars based in China, Canada and Hong Kong. Frequent co-authors include Pengfei Rong, Zhichao Feng, Wenhu Zhou, Mengtian Ma, Jiahao Liu, Xiao Hui Yang, Hongpei Tan, Dingbin Liu, Jianzhen Wu and Zhi-ru Zhu. Their work appears in journals such as Artificial Cells Nanomedicine and Biotechnology, Contrast Media & Molecular Imaging, Nature Communications, Journal of Controlled Release and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.